OCCLUFIT AG
Medtech / Cardiovascular medical devicesPatients requiring percutaneous treatment for left atrial appendage closure (LAAC), paravalvular leaks, and other congenital or acquired heart defects.
OCCLUFIT AG is a Swiss AG registered in Zürich, ZH. Its registered activity falls under Healthcare organisations.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~Small team including CEO Monica Tocchi, COO Andrea Guidotti, and CFO Amir GrossOfficers5Active Relations5Deleted Relations0SOGC Records6First Record12.12.2018Latest Activity29.11.2021MedtechCardiovascularMedical devicesUZH Spin-off
Registry Information
- Swiss UID
- CHE-148.534.743
- Legal Name
- OCCLUFIT AG
- Legal Form
- Limited or corporation
- Incorporated
- 12 Dec 2018
- Share Capital
- CHF 100'000.00
- Canton
- ZH
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Healthcare organisations
TOTHER SERVICE ACTIVITIES94Activities of membership organisations949Activities of other membership organisations9499Activities of other membership organisations n.e.c.949902
Industry Health
Registered Address
Schaffhauserstrasse 611
8052, Zürich, ZH
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients requiring percutaneous treatment for left atrial appendage closure (LAAC), paravalvular leaks, and other congenital or acquired heart defects.
Sources (5)
UZH Spin-offs & Startups | Innovation Hub | UZH
innovation.uzh.ch
SHAB Entries · Mercury-Reports
mercury-reports.com
UZH Life Sciences Fund investiert in Occlufit | Greater Zurich
greaterzuricharea.com
Guidotti Andrea, Zollikon | OnlineInfo.ch Personeninformation
onlineinfo.ch
Unternehmertum an der UZH fördern – UZH Foundation
uzhfoundation.ch